These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30407922)

  • 21. Recommendations for Improving the Quality of Rare Disease Registries.
    Kodra Y; Weinbach J; Posada-de-la-Paz M; Coi A; Lemonnier SL; van Enckevort D; Roos M; Jacobsen A; Cornet R; Ahmed SF; Bros-Facer V; Popa V; Van Meel M; Renault D; von Gizycki R; Santoro M; Landais P; Torreri P; Carta C; Mascalzoni D; Gainotti S; Lopez E; Ambrosini A; Müller H; Reis R; Bianchi F; Rubinstein YR; Lochmüller H; Taruscio D
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30081484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The EuRRECa Project as a Model for Data Access and Governance Policies for Rare Disease Registries That Collect Clinical Outcomes.
    Ali SR; Bryce J; Tan LE; Hiort O; Pereira AM; van den Akker ELT; Appelman-Dijkstra NM; Bertherat J; Cools M; Dekkers OM; Kodra Y; Persani L; Smyth A; Smythe C; Taruscio D; Ahmed SF
    Int J Environ Res Public Health; 2020 Nov; 17(23):. PubMed ID: 33255540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic testing in inherited endocrine disorders: joint position paper of the European reference network on rare endocrine conditions (Endo-ERN).
    Eggermann T; Elbracht M; Kurth I; Juul A; Johannsen TH; Netchine I; Mastorakos G; Johannsson G; Musholt TJ; Zenker M; Prawitt D; Pereira AM; Hiort O;
    Orphanet J Rare Dis; 2020 Jun; 15(1):144. PubMed ID: 32513286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ORPHAcodes use for the coding of rare diseases: comparison of the accuracy and cross country comparability.
    Mazzucato M; Pozza LVD; Facchin P; Angin C; Agius F; Cavero-Carbonell C; Corrochano V; Hanusova K; Kirch K; Lambert D; Lucano C; Maiella S; Panzaru M; Rusu C; Weber S; Zurriaga O; Zvolsky M; Rath A
    Orphanet J Rare Dis; 2023 Sep; 18(1):267. PubMed ID: 37667299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards European harmonisation of healthcare for patients with rare immune disorders: outcome from the ERN RITA registries survey.
    Papa R; Cant A; Klein C; Little MA; Wulffraat NM; Gattorno M; Ruperto N;
    Orphanet J Rare Dis; 2020 Jan; 15(1):33. PubMed ID: 32000824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of a European registry for pituitary adenomas: the example of Cushing's syndrome registry.
    Webb SM; Santos A; Valassi E
    Ann Endocrinol (Paris); 2012 Apr; 73(2):83-9. PubMed ID: 22541996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. National registries of rare diseases in Europe: an overview of the current situation and experiences.
    Taruscio D; Vittozzi L; Choquet R; Heimdal K; Iskrov G; Kodra Y; Landais P; Posada M; Stefanov R; Steinmueller C; Swinnen E; Van Oyen H
    Public Health Genomics; 2015; 18(1):20-5. PubMed ID: 25228300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The European Paediatric Rare Tumours Network - European Registry (PARTNER) project for very rare tumors in children.
    Orbach D; Ferrari A; Schneider DT; Reguerre Y; Godzinski J; Bien E; Stachowicz-Stencel T; Surun A; Almaraz RL; Dragomir M; Jani D; Ami TB; Roganovic J; Brecht IB; Ladenstein R; Bisogno G
    Pediatr Blood Cancer; 2021 Jun; 68 Suppl 4():e29072. PubMed ID: 33913610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telemedicine strategy of the European Reference Network ITHACA for the diagnosis and management of patients with rare developmental disorders.
    Smith M; Alexander E; Marcinkute R; Dan D; Rawson M; Banka S; Gavin J; Mina H; Hennessy C; Riccardi F; Radio FC; Havlovicova M; Cassina M; Emandi AC; Fradin M; Gompertz L; Nordgren A; Traberg R; Rossi M; Trimouille A; Sowmyalakshmi R; Dallapiccola B; Renieri A; Faivre L; Kerr B; Verloes A; Clayton-Smith J; Douzgou S;
    Orphanet J Rare Dis; 2020 Apr; 15(1):103. PubMed ID: 32334637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Tuscany Regional Network for rare diseases: from European Reference Networks' experience to registry based organisation and management model for rare diseases.
    Pieroni F; Marrucci S; Di Pietro L; Berni C; Scaletti C
    Orphanet J Rare Dis; 2023 Oct; 18(1):324. PubMed ID: 37833795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The need for widely available genomic testing in rare eye diseases: an ERN-EYE position statement.
    Black GC; Sergouniotis P; Sodi A; Leroy BP; Van Cauwenbergh C; Liskova P; Grønskov K; Klett A; Kohl S; Taurina G; Sukys M; Haer-Wigman L; Nowomiejska K; Marques JP; Leroux D; Cremers FPM; De Baere E; Dollfus H;
    Orphanet J Rare Dis; 2021 Mar; 16(1):142. PubMed ID: 33743793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients' priorities and expectations on an EU registry for rare bone and mineral conditions.
    Javaid MK; Mordenti M; Boarini M; Sangiorgi L; ; Westerheim I; Alves I; Skarberg RT; Appelman-Dijkstra NM; Grasemann C
    Orphanet J Rare Dis; 2021 Nov; 16(1):463. PubMed ID: 34732217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coding undiagnosed rare disease patients in health information systems: recommendations from the RD-CODE project.
    Angin C; Mazzucato M; Weber S; Kirch K; Abdel Khalek W; Ali H; Maiella S; Olry A; Jannot AS; Rath A
    Orphanet J Rare Dis; 2024 Jan; 19(1):28. PubMed ID: 38280999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A model for the European platform for rare disease registries.
    Vittozzi L; Gainotti S; Mollo E; Donati C; Taruscio D
    Public Health Genomics; 2013; 16(6):299-304. PubMed ID: 24503590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. eHealth Services for the European Reference Network on Rare Anaemias (eENERCA).
    Antoniou Z; Schiza EC; Neokleous K; Angastiniotis M; Pattichis CS; Schizas CN
    Stud Health Technol Inform; 2015; 213():153-6. PubMed ID: 26152979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients' perception on the quality of care for multiple endocrine neoplasia disorders in Europe: an online survey from a patient support group.
    Drewitz KP; Grey J; Brügmann P; Pichl J; Sammarco M; Aarts M; van Genechten D; Brandi ML; Schaaf L
    Endocrine; 2021 Mar; 71(3):634-640. PubMed ID: 33537957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Towards FAIRification of sensitive and fragmented rare disease patient data: challenges and solutions in European reference network registries.
    Dos Santos Vieira B; Bernabé CH; Zhang S; Abaza H; Benis N; Cámara A; Cornet R; Le Cornec CMA; 't Hoen PAC; Schaefer F; van der Velde KJ; Swertz MA; Wilkinson MD; Jacobsen A; Roos M
    Orphanet J Rare Dis; 2022 Dec; 17(1):436. PubMed ID: 36517834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Patient database and orphan drug development].
    Mizushima H; Tanabe M; Kanatani Y
    Yakugaku Zasshi; 2014; 134(5):599-605. PubMed ID: 24790040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rare disease registries: a call to action.
    Lacaze P; Millis N; Fookes M; Zurynski Y; Jaffe A; Bellgard M; Winship I; McNeil J; Bittles AH
    Intern Med J; 2017 Sep; 47(9):1075-1079. PubMed ID: 28891182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Healthcare networks for people with rare diseases: integrating data and expertise].
    Graessner H; Storf H; Schaefer F
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Nov; 65(11):1164-1169. PubMed ID: 36167994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.